Patient Advocates, Physicians, Lawmakers Call For Changes To Medicare Dialysis Drug Reimbursements

The House Ways and Means Health Subcommittee on Tuesday held a hearing to consider proposals to revise the Medicare reimbursement system for anemia medications administered to kidney dialysis patients, Dow Jones reports. Several studies in recent years have found that the system provides an incentive for dialysis centers to overprescribe anemia medications, according to CMS. [click link for full …

Read more here…

Leave a Reply

You must be logged in to post a comment.